# | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
---|
HeartBeam (NASDAQ:BEAT) reported quarterly losses of $(0.15) per share which met the analyst consensus estimate. This is a 21.0...
HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful personal...
HeartBeam (NASDAQ:BEAT) reported quarterly losses of $(0.18) per share which missed the analyst consensus estimate of $(0.15) b...